

Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1039, 2005-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Pioglitazone takes a proactive stance in type 2 diabetes
Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. :


Australia's TGA and NZ's Medsafe to merge
Reactions Weekly, Vol. 1, Iss. 1357, 2011-01 ,pp. :


Towards understanding: COX-2s and cardiovascular disorders
Reactions Weekly, Vol. 1, Iss. 1036, 2005-01 ,pp. :


More on COX-2s and cardiovascular risk but unlikely to be last word
Reactions Weekly, Vol. 1, Iss. 1039, 2005-01 ,pp. :


More on COX-2s and cardiovascular risk but unlikely to be last word
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :